Contrarily, another study found that in patients with the GCB subtype of DLBCL treated with R-CHOP, high miR-155 levels correlated with more favorable outcomes, independent of IPI score [38]. This evidence concerns the gene DDIT3 and diffuse large B-cell lymphoma.